- Home
- HUMA vs WLKP Comparison
HUMA vs WLKP Comparison
Compare HUMA & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- WLKP
- Stock Information
- Founded
- HUMA 2004
- WLKP 2014
- Country
- HUMA United States
- WLKP United States
- Employees
- HUMA N/A
- WLKP N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- WLKP Major Chemicals
- Sector
- HUMA Health Care
- WLKP Industrials
- Exchange
- HUMA Nasdaq
- WLKP Nasdaq
- Market Cap
- HUMA 679.3M
- WLKP 791.6M
- IPO Year
- HUMA N/A
- WLKP 2014
- Fundamental
- Price
- HUMA $5.26
- WLKP $22.52
- Analyst Decision
- HUMA Strong Buy
- WLKP
- Analyst Count
- HUMA 8
- WLKP 0
- Target Price
- HUMA $11.50
- WLKP N/A
- AVG Volume (30 Days)
- HUMA 3.2M
- WLKP 24.6K
- Earning Date
- HUMA 11-08-2024
- WLKP 11-05-2024
- Dividend Yield
- HUMA N/A
- WLKP 8.37%
- EPS Growth
- HUMA N/A
- WLKP 8.59
- EPS
- HUMA N/A
- WLKP 1.75
- Revenue
- HUMA N/A
- WLKP $1,143,109,000.00
- Revenue This Year
- HUMA N/A
- WLKP N/A
- Revenue Next Year
- HUMA $4,615.69
- WLKP $5.56
- P/E Ratio
- HUMA N/A
- WLKP $12.88
- Revenue Growth
- HUMA N/A
- WLKP N/A
- 52 Week Low
- HUMA $2.08
- WLKP $21.16
- 52 Week High
- HUMA $9.97
- WLKP $23.68
- Technical
- Relative Strength Index (RSI)
- HUMA 47.00
- WLKP 47.99
- Support Level
- HUMA $5.06
- WLKP $22.29
- Resistance Level
- HUMA $5.63
- WLKP $22.89
- Average True Range (ATR)
- HUMA 0.34
- WLKP 0.27
- MACD
- HUMA 0.00
- WLKP -0.01
- Stochastic Oscillator
- HUMA 35.65
- WLKP 24.62
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.